Not Yet RecruitingNCT07328594
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking
This study assesses sleep quality.
Medication studyAges 18–55United StatesAddiction
Understand this study
What is this study about?
This study assesses sleep quality.
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- PortlandSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: February 10, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 44
- Sponsor
- Legacy Health System
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT07328594
- Official title
Show the full official title
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking During Abstinence
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Portland
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses sleep quality.
Who is behind this study?
The study sponsor is Legacy Health System.
Does this study involve medication?
Yes. The study involves medication, including Daridorexant 50 mg.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
